Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Assets Average (2016 - 2025)

Angiodynamics (ANGO) has disclosed Assets Average for 14 consecutive years, with $267.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average changed N/A year-over-year to $267.7 million, compared with a TTM value of $267.7 million through Nov 2025, changed N/A, and an annual FY2025 reading of $298.9 million, down 29.69% over the prior year.
  • Assets Average was $267.7 million for Q4 2025 at Angiodynamics, down from $272.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $585.4 million in Q1 2021 and bottomed at $267.7 million in Q4 2025.
  • Average Assets Average over 4 years is $493.5 million, with a median of $548.6 million recorded in 2022.
  • The sharpest move saw Assets Average fell 19.64% in 2021, then grew 0.54% in 2022.
  • Year by year, Assets Average stood at $554.9 million in 2021, then rose by 0.54% to $557.9 million in 2022, then decreased by 10.97% to $496.8 million in 2023, then tumbled by 46.12% to $267.7 million in 2025.
  • Business Quant data shows Assets Average for ANGO at $267.7 million in Q4 2025, $272.9 million in Q3 2025, and $282.8 million in Q2 2025.